Development of a new nano-immune agonist to improve immunotherapy for melanoma, a challenging skin cancer, by changing the ...

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...

A study suggests that antibiotic use within one month of immune checkpoint inhibitor treatment may undermine survival in ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for ...

Scientists discover how to rouse the immune system around "cold" tumors, making them vulnerable to cancer-killing immune ...

Study Identifies Subtypes of Fibroblasts in Skin Cancer Nov. 19 ... melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or ...

The first patient with small cell lung cancer has been dosed in a phase 1/2 trial investigating first-line iadademstat plus ...

Optune Lua received a CE Mark for metastatic non–small cell lung cancer with immune checkpoint inhibitors or docetaxel.

Patients who discontinued cancer immunotherapy because of immune-related adverse events (irAEs) often had durable benefits ...

The study reexamined immunotherapy clinical trial data on bladder and skin cancer and ... tumors responsive to immune checkpoint blockade, Journal for ImmunoTherapy of Cancer (2025).